Baptist Health Miami Neuroscience Institute Advances Parkinson’s Disease Imaging With Specialized MRI Protocol
-
May 11, 2026
-
5 min
May 11, 2026
May 11, 2026
Phase 3 ADAPT SERON data supported efgartigimod use across antibody subtypes often underrepresented in trials.
May 11, 2026
Epilepsy remains a life-altering condition, particularly due to the unpredictable nature of seizures and their cumulative impact on cognition, independence and quality of life.
Integrated neuromonitoring approaches may help identify neurologic complications earlier in patients admitted to ICU.
May 7, 2026